Troxacitabine (BCH 4556; L-OddC; SPD 758) supplier | Troxacitabine (BCH 4556; L-OddC; SPD 758) manufacturer | Troxacitabine (BCH 4556; L-OddC; SPD 758) distributor

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
2 mg	3-5 days	￥1366.00	Visible after login	- +
5 mg	3-5 days	￥2636.00	Visible after login	- +
10 mg	3-5 days	￥4366.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

2 mg

3-5 days

￥1366.00

Visible after login

- +

5 mg

3-5 days

￥2636.00

Visible after login

- +

10 mg

3-5 days

￥4366.00

Visible after login

- +

Product Overview

Product Name	Troxacitabine (Synonyms: BCH 4556; L-OddC; SPD 758)
CAS	145918-75-8
Formula	C8H11N3O4
MW	213.19
MDL	MFCD00871100
Appearance	White to off-white powder
Storage condition	4°C, protect from light

Product details

Troxacitabine, a DNA polymerase inhibitor, shows potential in treating acute myeloid leukemia (AML) and has demonstrated activity against pancreatic cancer cell lines MiaPaCa and Panc-01, with greater efficacy against Panc-01. As a nucleoside analog, it possesses significant anticancer properties.

Related literature

The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity againstpancreatic human tumor xenografts.

PMID: 10778991

Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts

PMID: 12451476 DOI: 10.1007/s00280-002-0530-7

Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.

PMID: 9354442

Sorry, no related items

History

CL3055

Troxacitabine (Synonyms: BCH 4556; L-OddC; SPD 758)

145918-75-8 98+%